Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy

Journal of Ultrasound in Medicine

Volumn 24, Issue 7, 2005, Pages 885-895

  Roubidoux, Marilyn A ^a,f   LeCarpentier, Gerald L ^a   Fowlkes, J Brian ^a   Bartz, Brett ^b   Pai, Deepa ^d   Gordon, Sasha P ^e   Schott, Anne F ^b   Johnson, Timothy D ^c   Carson, Paul L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Oakwood Healthcare Inc   (United States)

^e PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Breast cancer; Breast sonography; Neoadjuvant chemotherapy

Indexed keywords

BIOPSY; CHEMOTHERAPY; IMAGING TECHNIQUES; RADIOLOGY; SENSITIVITY ANALYSIS; TUMORS;

BREAST CANCER; DOPPLER IMAGING; SONOGRAPHY;

ULTRASONICS;

DOCETAXEL; DOXORUBICIN;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFECT; DRUG RESPONSE; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MASTECTOMY; PARTIAL MASTECTOMY; SENSITIVITY ANALYSIS; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

EID: 21244488242     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2005.24.7.885     Document Type: Article

References (25)

1. Green M, Hortobagyi GN. Neoadjuvant chemotherapy for operable breast cancer. Oncology 2002; 16:871-884.
2. Ganem G, Tubiana-Hulin M, Fumoleau P, et al. Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer. Ann Oncol 2003; 14:1623-1628.
3. Forouhi P, Walsh JS, Anderson TJ, Chetty U. Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment. Br J Surg 1994; 81:223-225.
4. Balu-Maestro C, Chapellier C, Bleuse A, Chanalet I, Chauvel C, Largillier R. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 2002; 72:145-152.
5. Warren RM, Bobrow LG, Earl HM, et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 2004; 90:1349-1360.
6. Golshan M, Fung BB, Wiley E, Wolfman J, Rademaker A, Morrow M. Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast 2004; 13:265-271.
7. Helvie MA, Joynt LK, Cody RL, Pierce LJ, Adler DD, Merajver SD. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy Radiology 1996; 198:327-332.
8. Mankoff DA, Dunnwald LK, Gralow JR, et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002; 43:500-509.
9. Bhatti PT, LeCarpentier GL, Roubidoux MA, Fowlkes JB, Helvie MA, Carson PL. Discrimination of sonographically detected breast masses using frequency shift color Doppler imaging in combination with age and gray scale criteria. J Ultrasound Med 2001; 20: 343-350.
10. LeCarpentier GL, Tridandapani P, Fowlkes JB, Roubidoux MA, Moskalik AP, Carson PL. Utility of 3D ultrasound in the discrimination and detection of breast cancer. RSNA EJ 1999. Available at: http://ej.rsna.org/ej3/0103-99.fin/ titlepage.html.
11. American College of Radiology. ACR Practice Guideline for the Performance of Ultrasound-Guided Percutaneous Breast Interventional Procedures. Reston, VA: American College of Radiology; 2003.
12. Chang J, Powles TJ, Allred DC, et al. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol 1999; 17:3058-3063.
13. Fornage BD, Toubas O, Morel M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer 1987; 60:765-771.
14. Yang WT, Lam WW, Cheung H, Suen M, King WW, Metreweli C. Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med 1997; 16:791-797.
15. Hieken TJ, Harrison J, Herreros J, Velasco JM. Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg 2001; 182:351-354.
16. Zeggelink WF, Deurloo EE, Bartelink H, Rutgers EJ, Gilhuijs KG. Reproduclbility of the assessment of tumor extent in the breast using multiple image modalities. Med Phys 2003; 30:2919-2926.
17. Londero V, Bazzocchi M, Del Frate C, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004; 14:1371-1379.
18. Huber S, Medl M, Helbich T, et al. Locally advanced breast carcinoma: computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy. J Ultrasound Med 2000; 19:601-607.
19. Rosen EL, Blackwell KL, Baker JA, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 2003; 181:1275-1282.
20. Denis F, Desbiez-Bourcier AV, Chapiron C, Arbion F, Body G, Brunereau L. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 2004; 30: 1069-1076.
21. Rajan R, Esteva FJ, Symmans WF. Pathologic changes in breast cancer following neoadjuvant chemotherapy: implications for the assessment of response. Clin Breast Cancer 2004; 5:235-238.
22. Honkoop AH, Pinedo HM, De Jong JS, et al. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 1997; 107:211-218.
23. Anderson TJ, Dixon JM, Stuart M, Sahmoud T, Miller WR. Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer. Br J Cancer 2002; 87:334-338.
24. Guo XL, Lan GJ, Zhao H, et al. Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. World J Gastroenterol 2003; 9:1995-1998.
25. Mankoff DA, Dunnwald LK, Gralow JR, et al. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 2003; 44:1806-1814.